US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.695
  • -0.055-1.16%
Trading Jan 24 10:05 ET
139.02MMarket Cap-6.06P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telomir Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--------
--------
--------

Unlock Free Earnings Estimates

Telomir Pharmaceuticals Earnings Reports

  • Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:50 ET

  • Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 16:09 ET

  • Telomir Pharmaceuticals | 10-Q: Quarterly report

    May 13, 2024 16:36 ET

  • Telomir Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 29, 2024 17:33 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    SilverCrest Metals
    SILV
    +2.81%
    Constellation Brands
    STZ
    +1.58%
    Collegium Pharmaceutical
    COLL
    +1.54%
    Workday
    WDAY
    +0.94%
    DexCom
    DXCM
    +0.38%

    Unlock the Full List